BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 20708050)

  • 1. Selectively targeting estrogen receptors for cancer treatment.
    Shanle EK; Xu W
    Adv Drug Deliv Rev; 2010 Oct; 62(13):1265-76. PubMed ID: 20708050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of specific target genes and biological responses by estrogen receptor subtype agonists.
    Leitman DC; Paruthiyil S; Vivar OI; Saunier EF; Herber CB; Cohen I; Tagliaferri M; Speed TP
    Curr Opin Pharmacol; 2010 Dec; 10(6):629-36. PubMed ID: 20951642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective estrogen receptor modulators (SERMs): mechanisms of anticarcinogenesis and drug resistance.
    Lewis JS; Jordan VC
    Mutat Res; 2005 Dec; 591(1-2):247-63. PubMed ID: 16083919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lead Optimization of Benzoxepin-Type Selective Estrogen Receptor (ER) Modulators and Downregulators with Subtype-Specific ERα and ERβ Activity.
    O'Boyle NM; Barrett I; Greene LM; Carr M; Fayne D; Twamley B; Knox AJS; Keely NO; Zisterer DM; Meegan MJ
    J Med Chem; 2018 Jan; 61(2):514-534. PubMed ID: 28426931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of stable reporter breast cancer cell lines for the identification of ER subtype selective ligands.
    Shanle EK; Hawse JR; Xu W
    Biochem Pharmacol; 2011 Dec; 82(12):1940-9. PubMed ID: 21924251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular mechanisms of estrogen action: selective ligands and receptor pharmacology.
    Katzenellenbogen BS; Choi I; Delage-Mourroux R; Ediger TR; Martini PG; Montano M; Sun J; Weis K; Katzenellenbogen JA
    J Steroid Biochem Mol Biol; 2000 Nov; 74(5):279-85. PubMed ID: 11162936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenytoin is an estrogen receptor α-selective modulator that interacts with helix 12.
    Fadiel A; Song J; Tivon D; Hamza A; Cardozo T; Naftolin F
    Reprod Sci; 2015 Feb; 22(2):146-55. PubMed ID: 25258361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of a multi-target compound for estrogen receptor-positive (ER
    Almeida CF; Teixeira N; Oliveira A; Augusto TV; Correia-da-Silva G; Ramos MJ; Fernandes PA; Amaral C
    Biochimie; 2021 Feb; 181():65-76. PubMed ID: 33278557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential of endogenous estrogen receptor beta to influence the selective ER modulator ERbeta complex.
    Chen B; Gajdos C; Dardes R; Kidwai N; Johnston SR; Dowsett M; Jordan VC
    Int J Oncol; 2005 Aug; 27(2):327-35. PubMed ID: 16010412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell proliferation and modulation of interaction of estrogen receptors with coregulators induced by ERα and ERβ agonists.
    Evers NM; van den Berg JH; Wang S; Melchers D; Houtman R; de Haan LH; Ederveen AG; Groten JP; Rietjens IM
    J Steroid Biochem Mol Biol; 2014 Sep; 143():376-85. PubMed ID: 24923734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective activation of estrogen receptor-beta transcriptional pathways by an herbal extract.
    Cvoro A; Paruthiyil S; Jones JO; Tzagarakis-Foster C; Clegg NJ; Tatomer D; Medina RT; Tagliaferri M; Schaufele F; Scanlan TS; Diamond MI; Cohen I; Leitman DC
    Endocrinology; 2007 Feb; 148(2):538-47. PubMed ID: 17095596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological evaluation of novel cyclopropyl derivatives as subtype-selective ligands for estrogen receptor.
    Wang Z; Yang Y; Zheng X; Zhang T; Huang W; Yan D; Zhang W; Wang X; Shen Z
    J Pharm Pharmacol; 2018 Jul; 70(7):910-918. PubMed ID: 29582419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of ligands with bicyclic scaffolds provides insights into mechanisms of estrogen receptor subtype selectivity.
    Hsieh RW; Rajan SS; Sharma SK; Guo Y; DeSombre ER; Mrksich M; Greene GL
    J Biol Chem; 2006 Jun; 281(26):17909-19. PubMed ID: 16648639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-function relationship of estrogen receptors in cardiovascular pathophysiological models.
    Arnal JF; Valéra MC; Payrastre B; Lenfant F; Gourdy P
    Thromb Res; 2012 Oct; 130 Suppl 1():S7-11. PubMed ID: 23026669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen receptor transcription and transactivation: Estrogen receptor alpha and estrogen receptor beta: regulation by selective estrogen receptor modulators and importance in breast cancer.
    Katzenellenbogen BS; Katzenellenbogen JA
    Breast Cancer Res; 2000; 2(5):335-44. PubMed ID: 11250726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estradiol and selective estrogen receptor modulators differentially regulate target genes with estrogen receptors alpha and beta.
    Tee MK; Rogatsky I; Tzagarakis-Foster C; Cvoro A; An J; Christy RJ; Yamamoto KR; Leitman DC
    Mol Biol Cell; 2004 Mar; 15(3):1262-72. PubMed ID: 14699072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ERbeta in breast cancer--onlooker, passive player, or active protector?
    Fox EM; Davis RJ; Shupnik MA
    Steroids; 2008 Oct; 73(11):1039-51. PubMed ID: 18501937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benzothiophene selective estrogen receptor modulators with modulated oxidative activity and receptor affinity.
    Qin Z; Kastrati I; Chandrasena RE; Liu H; Yao P; Petukhov PA; Bolton JL; Thatcher GR
    J Med Chem; 2007 May; 50(11):2682-92. PubMed ID: 17489582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen receptors and their downstream targets in cancer.
    Ikeda K; Inoue S
    Arch Histol Cytol; 2004 Dec; 67(5):435-42. PubMed ID: 15781984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting estrogen receptor subtypes (ERα and ERβ) with selective ER modulators in ovarian cancer.
    Chan KK; Leung TH; Chan DW; Wei N; Lau GT; Liu SS; Siu MK; Ngan HY
    J Endocrinol; 2014 May; 221(2):325-36. PubMed ID: 24819599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.